US Map / North Dakota
State ND

Clinical Trials in North Dakota

North Dakota is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in North Dakota and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.

Right now ClinicalMetric tracks 37 actively recruiting studies with North Dakota sites out of 37 registered in total. The busiest research areas in North Dakota are Stage IVB Prostate Cancer AJCC v8, Lung Non-Small Cell Carcinoma, Anatomic Stage II Breast Cancer AJCC v8. Leading sponsors running trials in the state include National Cancer Institute (NCI), Alliance for Clinical Trials in Oncology, Children's Oncology Group. By stage, North Dakota trials break down as Phase 1 (1), Phase 2 (11), Phase 3 (24), Phase 4 (1).

All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.

Total Trials
37
Recruiting Now
37
← Back to US Map
Top Conditions in North Dakota
Stage IVB Prostate Cancer AJCC v8 (2)Lung Non-Small Cell Carcinoma (2)Anatomic Stage II Breast Cancer AJCC v8 (2)Neovascular Age-related Macular Degeneration (1)HPV-unrelated Head and Neck Squamous Cell Carcinoma (1)Metastatic Castration-Resistant Prostate Carcinoma (1)Metastatic Prostate Adenocarcinoma (1)Recurrent Head and Neck Squamous Cell Carcinoma (1)Recurrent Hypopharyngeal Squamous Cell Carcinoma (1)Recurrent Laryngeal Squamous Cell Carcinoma (1)Recurrent Oral Cavity Squamous Cell Carcinoma (1)Recurrent Oropharyngeal Squamous Cell Carcinoma (1)

Frequently Asked Questions — Clinical Trials in North Dakota

How many clinical trials are currently recruiting in North Dakota?
ClinicalMetric currently tracks 37 actively recruiting clinical trials with at least one location in North Dakota. The total number of registered studies—including active but not currently enrolling trials—is 37. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in North Dakota?
North Dakota hosts clinical trials across a broad range of medical conditions, including Stage IVB Prostate Cancer AJCC v8, Lung Non-Small Cell Carcinoma, Anatomic Stage II Breast Cancer AJCC v8, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout North Dakota serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in North Dakota?
To join a clinical trial in North Dakota, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in North Dakota maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.

Recruiting Trials in North Dakota

NCT04853251 Phase 4
Recruiting
A Study Assessing Corneal Endothelial Cells in Participants With Neovascular Age...
Condition
Neovascular Age-related Macular Degeneration
Enrollment
188 pts
Location
United States
Sponsor
Genentech, Inc.
View Trial →
NCT04966481 Phase 3
Recruiting
Palbociclib and Cetuximab Versus Cetuximab Monotherapy for Patients With CDKN2A-...
Condition
HPV-unrelated Head and Neck Squamous Cell Carcinoma
Enrollment
81 pts
Location
United States
Sponsor
Washington University School o
View Trial →
NCT07200830 Phase 3
Recruiting
Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA ...
Condition
Metastatic Castration-Resistant Prostate Carcinoma
Enrollment
1,524 pts
Location
United States
Sponsor
Alliance for Clinical Trials i
View Trial →
NCT04671667 Phase 2
Recruiting
Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itse...
Condition
Recurrent Head and Neck Squamous Cell Carcinoma
Enrollment
188 pts
Location
United States
Sponsor
National Cancer Institute (NCI
View Trial →
NCT06383273 Phase 3
Recruiting
A Study to Evaluate Efficacy and Safety of MELT-300 for Procedural Sedation in S...
Condition
Cataract
Enrollment
528 pts
Location
United States
Sponsor
Melt Pharmaceuticals
View Trial →
NCT05136196 Phase 2
Recruiting
BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Tr...
Condition
Clinical Stage III Cutaneous Melanoma AJCC v8
Enrollment
150 pts
Location
United States
Sponsor
National Cancer Institute (NCI
View Trial →
NCT06172296 Phase 3
Recruiting
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Tre...
Condition
Ganglioneuroblastoma, Nodular
Enrollment
478 pts
Location
United States, Australia, Canada
Sponsor
National Cancer Institute (NCI
View Trial →
NCT06548360 Phase 3
Recruiting
A Study to Evaluate the Safety and Efficacy of Ruxolitinib Cream in Pediatric Pa...
Condition
NonSegmental Vitiligo
Enrollment
180 pts
Location
United States, Canada
Sponsor
Incyte Corporation
View Trial →
NCT06963723 N/A
Recruiting
Longitudinal Screening for Financial Hardship to Improve Outcomes in Patients Wi...
Condition
Advanced Cancer
Enrollment
1,000 pts
Location
United States, Puerto Rico
Sponsor
Alliance Foundation Trials, LL
View Trial →
NCT04566328 Phase 3
Recruiting
Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Mu...
Condition
Plasma Cell Myeloma
Enrollment
1,450 pts
Location
United States, Puerto Rico
Sponsor
ECOG-ACRIN Cancer Research Gro
View Trial →
NCT06337318 Phase 3
Recruiting
Comparing Rituximab and Mosunetuzumab Drug Treatments for People With Low Tumor ...
Condition
Classic Follicular Lymphoma
Enrollment
600 pts
Location
United States
Sponsor
National Cancer Institute (NCI
View Trial →
NCT06524882 Phase 3
Recruiting
Dichoptic Treatment for Amblyopia in Children 8 to 12 Years of Age
Condition
Amblyopia
Enrollment
252 pts
Location
United States
Sponsor
Jaeb Center for Health Researc
View Trial →
NCT07198074 Phase 3
Recruiting
Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Ca...
Condition
Advanced Endometrial Carcinoma
Enrollment
255 pts
Location
United States
Sponsor
National Cancer Institute (NCI
View Trial →
NCT07553429 Phase 1, Phase 2
Recruiting
A Study in People With Diabetic Macular Edema to Test How Well Different Doses o...
Condition
Diabetic Macular Edema
Enrollment
49 pts
Location
United States, Puerto Rico
Sponsor
Boehringer Ingelheim
View Trial →
NCT01810913 Phase 2, Phase 3
Recruiting
Testing Docetaxel-Cetuximab or the Addition of an Immunotherapy Drug, Atezolizum...
Condition
Oropharyngeal p16INK4a-Negative Squamous Cell Carcinoma
Enrollment
613 pts
Location
United States, Canada, Hong Kong
Sponsor
National Cancer Institute (NCI
View Trial →
NCT03550391 Phase 3
Recruiting
Stereotactic Radiosurgery Compared With Hippocampal-Avoidant Whole Brain Radioth...
Condition
Brain Metastases
Enrollment
206 pts
Location
United States, Canada
Sponsor
Canadian Cancer Trials Group
View Trial →
NCT05235165 Phase 3
Recruiting
Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients ...
Condition
Metastatic Malignant Neoplasm in the Lung
Enrollment
62 pts
Location
United States, Australia, Canada
Sponsor
Children's Oncology Group
View Trial →
NCT02981628 Phase 2
Recruiting
Inotuzumab Ozogamicin in Treating Younger Patients With B-Lymphoblastic Lymphoma...
Condition
Recurrent B Acute Lymphoblastic Leukemia
Enrollment
80 pts
Location
United States, Puerto Rico
Sponsor
Children's Oncology Group
View Trial →
NCT06418204 N/A
Recruiting
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients T...
Condition
Breast Carcinoma
Enrollment
2,000 pts
Location
United States, Puerto Rico
Sponsor
Wake Forest University Health
View Trial →
NCT06632977 Phase 2
Recruiting
Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial
Condition
Castration-Resistant Prostate Carcinoma
Enrollment
474 pts
Location
United States
Sponsor
Alliance for Clinical Trials i
View Trial →
NCT06312137 Phase 3
Recruiting
A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzum...
Condition
Non Small Cell Lung Cancer
Enrollment
780 pts
Location
United States, Argentina, Australia
Sponsor
Merck Sharp & Dohme LLC
View Trial →
NCT06702033 Phase 2
Recruiting
The Minimalist Trial-2
Condition
HPV-Related Oropharynx Squamous Cell Carcinoma
Enrollment
142 pts
Location
United States
Sponsor
Washington University School o
View Trial →
NCT06592924 Phase 3
Recruiting
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Ca...
Condition
Prostate Cancer (Adenocarcinoma)
Enrollment
830 pts
Location
United States, Canada, Mexico
Sponsor
Canadian Cancer Trials Group
View Trial →
NCT04852887 Phase 3
Recruiting
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, O...
Condition
Stage I Breast Cancer
Enrollment
1,670 pts
Location
United States, Canada, Hong Kong
Sponsor
NRG Oncology
View Trial →
NCT07253285 Phase 3
Recruiting
A Research Study on How Well Cagrilintide and CagriSema Work in Children and Ado...
Condition
Overweight
Enrollment
460 pts
Location
United States, Australia, Austria
Sponsor
Novo Nordisk A/S
View Trial →
Page 1 of 2 — 37 trials total
Next →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology